Work

A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection

Year: 2023

Type: article

Source: The Lancet Infectious Diseases

DOI: 10.1016/s1473-3099(23)00215-3

Authors: Noé Brasier, H Ceren Ates, Juliane R Sempionatto, Menino O Cotta, Andreas F Widmer, Jens Eckstein, Jörg Goldhahn, Jason A Roberts, Wei Gao, Can Dincer

Institutions: University Hospital of Basel, ETH Zurich, Institute of Translational Medicine, University of Freiburg, California Institute of Technology, The University of Queensland, University of Basel, Université de Montpellier, Royal Brisbane and Women's Hospital, Centre Hospitalier Universitaire de Nîmes, Metro North Hospital and Health Service

Language: English

Topic: Antibiotics Pharmacokinetics and Efficacy

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, Eidgenössische Technische Hochschule Zürich, National Health and Medical Research Council

Awards: Translating precision antibiotic dosing into better outcomes for severe infections, Personalisierte Antibiotikatherapie: Entwicklung und Evaluierung einer mikrofluidischen BiosensorPlattform für die nichtinvasive, patientennahe MultianalytDiagnostik, Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND), MikrofluidikImpedanzBiosensorSystem für die simultane und labelfreie VorOrtDetektion des Blutgerinnungsstatus

OpenAlex ID: W4381162403

FWCI: 4.099

Cites: 70

Cited by: 32

Related to: 10